Release Date: 06/07/15 18:07 Summary: Amended- Updated Banfora Scoping Study increases NPV by 233% Price Sensitive: No Download Document 1.7MB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status